Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Clear Secure Inc (YOU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Clear Secure Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while Clear Secure Inc trades at $44.26 (market cap $4.57B). The key difference: Kymera Therapeutics Inc. Common Stock is the larger of the two by market cap, and Clear Secure Inc pays a 1.3% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Clear Secure Inc for 20 Days on average.
| KYMR | YOU | |
|---|---|---|
Market Cap | $8.88B | $4.57B |
Volume | 1,028,790 | 1,514,917 |
Sector | Health | Technology |
52-Week High | $127.31 | $62.36 |
52-Week Low | $55.80 | $30.47 |
Typical Hold Time | 0 Days | 20 Days |
Enterprise Value | $8.27B | $3.72B |
Dividend Yield | — | 1.3% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Clear Secure (YOU) trades at $43.52, up 2.5% with mixed technical signals showing bearish moving averages but neutral oscillators. The company demonstrates strong fundamentals with 27% revenue growth in Q2 2026, beating earnings estimates, and robust profitability metrics including 66.7% gross margins and 90.3% ROE. Recent developments include a strategic partnership with CrowdStrike and corporate membership launch.
The stock presents growth potential with a 41% upside to the $61.40 consensus target, supported by expanding profitability and market share gains. Key risks include competitive pressures in identity verification and potential execution challenges in new enterprise initiatives. Analyst sentiment is balanced with 44% buy ratings but technical resistance near $44-46 levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Clear Secure Inc
Clear Secure operates a secure identity platform that uses biometrics—specifically eyes, face, and fingerprints—to automate and expedite identity verification. While its most visible application is the CLEAR Plus airport subscription service, the company functions as a broad-based identity layer for travel, healthcare, and digital services, aiming to replace physical IDs with a secure, biometric link.
Read more on YOU →
